LMAT Stock Cash Flow Statements

LeMaitre Vascular Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

LeMaitre Vascular Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31

operating activities
net income	13,779,000	11,011,000	11,184,000	11,141,000	11,826,000	9,887,000	8,465,000	7,502,000	8,098,000	6,040,000	5,627,000	5,456,000	3,515,000	6,038,000	6,175,000	6,504,000	8,299,000	5,929,000	7,033,000	7,513,000	3,500,000	3,174,000	4,613,000	5,184,000	4,624,000	3,513,000	6,025,000	4,314,000	8,751,000	3,853,000	4,284,000	5,042,000	4,632,000	3,219,000	2,597,000	3,229,000	2,598,000	2,166,000	2,530,000	2,092,000	1,767,000	1,369,000	1,916,000	934,000	1,272,000	-207,000	746,000	721,000	889,000	846,000	698,000	663,000	824,000	386,000	346,000	1,214,000	519,000	64,000	1,964,000	1,517,000	1,511,000	1,021,000	1,269,000	1,285,000	925,000	-1,881,000	312,000	-137,000	-925,000	-2,564,000	-1,178,000	-1,354,000	227,000	-629,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	2,648,000	2,552,000	2,478,000	2,426,000	2,384,000	2,382,000	2,443,000	2,395,000	2,326,000	2,351,000	2,288,000	2,328,000	2,444,000	2,373,000	2,884,000	2,925,000	2,637,000	2,624,000	2,534,000	2,684,000	1,639,000	1,538,000	1,441,000	1,345,000	1,346,000	1,284,000	1,216,000	1,006,000	1,066,000	1,036,000	1,089,000	1,004,000	983,000	979,000	933,000	846,000	931,000	881,000	897,000	825,000	840,000	832,000	912,000	802,000	789,000	831,000	819,000	723,000	641,000	610,000	601,000	528,000	557,000	548,000	571,000	516,000	489,000	461,000	369,000	314,000	346,000	347,000	369,000	356,000	376,000	318,000	317,000	352,000	505,000	419,000	404,000	306,000	359,000	325,000
stock-based compensation	1,944,000	2,046,000	1,739,000	1,610,000	1,609,000	1,610,000	1,404,000	1,313,000	1,312,000	1,290,000	684,000	1,186,000	1,136,000	1,167,000	886,000	797,000	869,000	927,000	753,000	687,000	803,000	779,000	547,000	655,000	694,000	746,000	555,000	537,000	636,000	621,000	411,000	886,000	472,000	487,000	485,000	533,000	332,000	330,000	336,000	479,000	281,000	328,000	320,000	439,000	265,000	278,000	286,000	412,000	278,000	277,000	277,000	406,000	267,000	263,000	250,000	317,000	267,000	263,000	264,000	262,000	226,000	215,000	266,000	274,000	227,000	218,000	249,000	208,000	171,000	173,000	155,000	167,000	123,000	116,000
non-cash interest expense and end of term accretion expense	1,299,000	1,290,000
benefit from inventory write-downs	393,000	637,000	978,000	854,000	544,000	716,000	782,000	621,000	500,000	334,000	512,000	389,000	1,173,000	498,000	763,000	862,000	1,149,000	1,005,000	491,000	423,000	413,000	196,000	239,000	106,000	164,000	238,000	373,000	128,000	69,000	101,000	124,000	88,000	47,000	137,000	82,000	81,000	163,000	36,000	0	152,000	171,000	139,000	159,000	101,000	332,000	75,000	64,000	-16,000	328,000	103,000	-84,000	248,000	238,000	461,000	239,000	208,000	318,000	246,000	147,000	140,000	341,000	208,000	145,000	84,000	53,000	146,000	164,000	369,000	405,000	110,000
benefit from credit losses	325,000	12,000	317,000	96,000	38,000	362,000	284,000
fair value adjustments to contingent consideration obligations
foreign currency transaction effect on income	-260,000	-19,000
changes in operating assets and liabilities:
accounts receivable	-680,000	-4,619,000	1,017,000	-942,000	-743,000	-5,750,000	-1,058,000	2,162,000	-997,000	-3,242,000	-1,796,000	873,000	-659,000	-1,951,000	-393,000	1,061,000	-629,000	-857,000	387,000	-1,767,000	809,000	-368,000	-1,569,000	330,000	-92,000	30,000	-2,835,000	2,104,000	-1,123,000	571,000	-1,457,000	1,017,000	-209,000	-858,000	-854,000	708,000	49,000	-825,000	-801,000	771,000	-193,000	-1,656,000	-460,000	619,000	-881,000	68,000	-1,310,000	760,000	-251,000	-446,000	-539,000	337,000	-351,000	-87,000	248,000	-34,000	380,000	-768,000	-376,000	51,000	-134,000	-514,000	-75,000	100,000	-350,000	-161,000	-401,000	-30,000	-15,000	93,000	-822,000	90,000	-358,000	-589,000
inventory and other deferred costs	-2,120,000	-1,334,000	-1,642,000	-1,645,000	-3,750,000	-3,537,000	-2,212,000	-3,310,000	-517,000	-3,755,000	-2,377,000	-1,505,000	-2,269,000	-1,267,000	-2,733,000	-708,000	-698,000	-1,346,000	619,000	848,000	-2,215,000	-1,861,000	-1,759,000	-4,288,000	-2,918,000	-2,370,000	-1,201,000	-1,755,000	-498,000	-808,000	-22,000
prepaid expenses and other assets	-1,045,000	2,721,000	-2,395,000	-665,000	-1,487,000	2,216,000	-1,764,000	-2,082,000	-302,000	1,224,000	-1,752,000	-1,747,000	-1,289,000	1,692,000	-1,186,000	-1,188,000	-191,000	638,000	54,000	232,000	-856,000	659,000	-205,000	-1,164,000	976,000	-261,000	1,346,000	-1,790,000	-334,000	360,000	1,115,000	-647,000	-740,000	-16,000	1,918,000	-656,000	-561,000	827,000	-1,244,000	-239,000	-387,000	-165,000	956,000	-490,000	24,000	63,000	19,000	-469,000	262,000	-48,000	240,000	-361,000	398,000	26,000	277,000	-430,000	370,000	-112,000	-719,000	-94,000	138,000	-171,000	335,000	-59,000	138,000	196,000	293,000	603,000	175,000	-21,000	-1,524,000	261,000	-27,000	370,000
accounts payable and other liabilities	4,008,000	-5,258,000	1,760,000	1,796,000	-1,542,000	-2,793,000	2,346,000	3,240,000	1,353,000	-2,340,000	469,000	35,000	3,580,000	-3,439,000	-1,167,000	4,036,000	-1,618,000	-2,985,000	2,472,000	3,942,000	1,179,000	-3,271,000	1,435,000	2,063,000	-584,000	-3,510,000	4,659,000	-263,000	1,998,000	-2,080,000	737,000	1,337,000	-183,000	-367,000	-1,302,000	2,081,000	939,000	-1,821,000	2,403,000	632,000	705,000	-1,123,000	-782,000	944,000	564,000	-1,812,000	588,000	874,000	524,000	-1,125,000	-237,000	1,215,000	1,088,000	-709,000	-2,298,000	1,689,000	-399,000	-2,162,000	1,827,000	786,000	708,000	-194,000	-243,000	435,000	849,000	-884,000	177,000	-959,000	586,000	-2,499,000	1,660,000	1,292,000	-52,000	-480,000
net cash from operating activities	20,291,000	9,039,000	15,182,000	14,246,000	9,625,000	5,071,000	10,746,000	11,823,000	11,903,000	2,279,000	4,077,000	7,342,000	9,248,000	4,711,000	5,056,000	14,075,000	9,897,000	6,074,000	14,152,000	14,112,000	5,347,000	1,189,000	5,594,000	4,470,000	4,334,000	-219,000	6,571,000	4,308,000	4,876,000	3,751,000	6,770,000	8,198,000	5,424,000	2,476,000	4,194,000	6,350,000	5,094,000	1,258,000	3,925,000	4,211,000	3,902,000	-600,000	2,682,000	2,896,000	1,623,000	-1,689,000	1,356,000	2,391,000	1,987,000	-346,000	427,000	1,864,000	2,045,000	386,000	-303,000	2,375,000	3,202,000	-2,104,000	969,000	2,623,000	2,641,000	819,000	1,969,000	3,163,000	2,614,000	-2,306,000	2,468,000	1,310,000	1,152,000	-4,349,000	-470,000	485,000	27,000	-1,868,000
capex	-1,342,000	-1,383,000	-2,044,000	-1,670,000	-1,878,000	-1,370,000	0	-1,053,000	-2,803,000	-2,130,000	0	-460,000	-973,000	-536,000	0	-1,814,000	-1,403,000	-1,059,000	0	-593,000	-311,000	-863,000	0	-710,000	-849,000	-802,000	0	-534,000	-803,000	-427,000	0	-2,336,000	0	-1,691,000	0	-566,000	0	-720,000	-715,000	-765,000	-470,000	-323,000	-400,000	-225,000	-116,000	-433,000	-295,000	-380,000	-1,382,000	-676,000	-421,000	-204,000	-313,000	-271,000	-617,000	-650,000	-239,000	-515,000	0	-542,000	-340,000	-269,000	-104,000	-276,000	-120,000	-77,000	-40,000	-30,000	-256,000	-298,000	-294,000	-297,000	-298,000	-231,000
free cash flows	18,949,000	7,656,000	13,138,000	12,576,000	7,747,000	3,701,000	10,746,000	10,770,000	9,100,000	149,000	4,077,000	6,882,000	8,275,000	4,175,000	5,056,000	12,261,000	8,494,000	5,015,000	14,152,000	13,519,000	5,036,000	326,000	5,594,000	3,760,000	3,485,000	-1,021,000	6,571,000	3,774,000	4,073,000	3,324,000	6,770,000	5,862,000	5,424,000	785,000	4,194,000	5,784,000	5,094,000	538,000	3,210,000	3,446,000	3,432,000	-923,000	2,282,000	2,671,000	1,507,000	-2,122,000	1,061,000	2,011,000	605,000	-1,022,000	6,000	1,660,000	1,732,000	115,000	-920,000	1,725,000	2,963,000	-2,619,000	969,000	2,081,000	2,301,000	550,000	1,865,000	2,887,000	2,494,000	-2,383,000	2,428,000	1,280,000	896,000	-4,647,000	-764,000	188,000	-271,000	-2,099,000
investing activities
purchases of short-term marketable securities	-14,956,000	-2,893,000	-256,628,000	-11,194,000	-9,125,000	-991,000	-982,000	-8,330,000	-6,675,000	-564,000	0				-9,640,000			-1,000	-12,000	-15,000	-75,000	-2,103,000	-4,321,000	-5,203,000	-2,221,000	-10,954,000	-3,671,000	-5,191,000	-10,663,000	-94,000
purchases of property and equipment	-1,342,000	-1,383,000	-2,044,000	-1,670,000	-1,878,000	-1,370,000																												-1,691,000				-720,000	-715,000	-765,000	-470,000	-323,000	-400,000	-225,000	-116,000	-433,000	-295,000	-380,000	-1,382,000	-676,000	-421,000	-204,000	-313,000	-271,000	-617,000	-650,000	-239,000	-515,000		-542,000	-340,000	-269,000
payments related to acquisitions, net of cash acquired	-51,000	-44,000																																					-139,000	-158,000	-1,130,000	-138,000	-982,000
net cash from investing activities	-16,349,000	-4,320,000	-173,892,000	-12,864,000	-11,003,000	-2,361,000	-2,261,000	-9,851,000	-9,639,000	-2,964,000	-402,000	-8,460,000	-973,000	-536,000	-7,246,000	-51,368,000	-1,402,000	-1,060,000	3,673,000	1,347,000	-57,886,000	-25,000	-3,546,000	-5,728,000	-3,070,000	-11,756,000	1,257,000	-3,725,000	-4,066,000	-521,000	-24,178,000	-2,336,000	-753,000	-1,691,000	-13,013,000	-566,000	-530,000	-3,102,000	-865,000	-569,000	-1,585,000	-461,000	-1,388,000	-5,611,000	-110,000	-639,000	-318,000	-3,581,000	-1,494,000	-795,000	-4,531,000	-150,000	-205,000	-312,000	-1,141,000	632,000	-514,000	-799,000	-4,691,000	-383,000	-225,000	64,000	1,794,000	-98,000	-30,000	516,000	328,000	1,208,000	4,242,000	3,235,000	-3,094,000	-5,165,000	-772,000	-157,000
financing activities
proceeds from stock option exercises	1,760,000	1,312,000		449,000	730,000	3,986,000				1,446,000				508,000				1,385,000
deferred payments for acquisitions	0	-1,433,000
payment of withholding taxes in connection with net settlement of equity awards
common stock cash dividend paid	-4,520,000	-4,517,000	-3,600,000	-3,596,000	-3,593,000	-3,589,000	-3,116,000	-3,117,000	-3,116,000	-3,099,000	-2,750,000	-2,750,000	-2,745,000	-2,743,000	-2,406,000	-2,401,000	-2,267,000	-2,262,000	-1,936,000	-1,925,000	-1,917,000	-1,917,000	-1,701,000	-1,691,000			-1,372,000	-1,369,000			-1,060,000	-1,054,000			-836,000	-834,000			-725,000	-715,000	-705,000	-700,000	-608,000	-607,000			-464,000	-460,000			-378,000	-380,000			-308,000	-310,000	-309,000	-310,000
net cash from financing activities	-2,764,000	-5,239,000	164,081,000	-3,148,000	-2,870,000	39,000	-2,686,000	-3,122,000	502,000	-1,825,000	-2,122,000	-2,147,000	-2,585,000	-2,380,000	-1,159,000	33,365,000	-10,539,000	-7,965,000	-21,005,000	-6,474,000	61,375,000	-1,741,000	-2,220,000	16,000	-2,842,000	424,000	-1,303,000	0	-3,370,000	257,000			-711,000	559,000	-1,042,000	-507,000	-1,169,000	141,000	847,000	585,000	28,000	-381,000	-790,000	-2,158,000			48,000	-183,000	-906,000	80,000	-61,000	-1,255,000	-1,239,000	-602,000	-1,476,000	-1,236,000	-418,000	-670,000	-1,102,000	-510,000	-375,000	-348,000	-344,000	-41,000	-10,000	19,000			83,000	-176,000	-62,000	140,000	21,000	-89,000
effect of exchange rate changes on cash and cash equivalents	659,000	250,000	-762,000	499,000	-79,000	-423,000	419,000	-287,000	45,000	53,000	668,000	-610,000	-462,000	-90,000	-165,000	-244,000	60,000	-288,000	665,000	318,000	196,000	-265,000	239,000	-303,000	76,000	-1,000	-311,000	-117,000	-583,000	198,000	56,000	234,000	350,000	178,000	-501,000	58,000	-21,000	193,000	-85,000	-28,000	60,000	-225,000	-166,000	-285,000	8,000	-2,000	-1,000	89,000	21,000	-85,000	-26,000	18,000	-61,000	18,000	-35,000	-89,000	32,000	62,000	-15,000	115,000	-95,000	-65,000	-36,000	45,000	73,000	-31,000	-40,000	-96,000	21,000	43,000	330,000	-182,000	-43,000	-36,000
net increase in cash and cash equivalents	1,837,000	-270,000			-4,327,000	2,326,000	6,218,000	-1,437,000	2,811,000	-2,457,000	2,221,000	-3,875,000	5,228,000	1,705,000	-3,514,000	-4,172,000			-2,515,000	9,303,000	9,032,000	-842,000	67,000	-1,545,000	-1,502,000	-11,552,000	6,214,000	466,000	-3,143,000	3,685,000	-18,418,000	7,394,000	4,310,000	1,522,000	-10,362,000	5,335,000			3,822,000	4,199,000			338,000	-5,158,000				-1,284,000				477,000			-2,955,000	1,682,000	2,302,000	-3,511,000	-4,839,000	1,845,000	1,946,000	470,000	3,383,000	3,069,000			2,732,000	2,515,000
cash and cash equivalents at beginning of period	0	25,610,000		0	0	24,269,000		0	0	19,134,000		0	0	13,855,000		0	0	26,764,000		0	0	11,786,000		0	0	26,318,000		0	0	19,096,000		0	0	24,288,000		0	0	27,451,000		0	0	18,692,000		0	0	14,711,000		0	0	16,448,000		0	0	20,132,000		0	0	22,614,000		0	0	23,192,000		0	0	15,895,000		0	-294,000	6,691,000		0	0	15,391,000
cash and cash equivalents at end of period	1,837,000	25,340,000		-1,267,000	-4,327,000	26,595,000		-1,437,000	2,811,000	16,677,000		-3,875,000	5,228,000	15,560,000		-4,172,000	-1,984,000	23,525,000		9,303,000	9,032,000	10,944,000		-1,545,000	-1,502,000	14,766,000		466,000	-3,143,000	22,781,000		7,394,000	4,310,000	25,810,000		5,335,000	3,374,000	25,941,000		4,199,000	2,405,000	17,025,000		-5,158,000	11,008,000	12,504,000		-1,284,000	-392,000	15,302,000		477,000	540,000	19,622,000		1,682,000	2,302,000	19,103,000		1,845,000	1,946,000	23,662,000		3,069,000	2,647,000	14,093,000		2,515,000	5,204,000	5,444,000		-4,722,000	-767,000	13,241,000
non-cash operating activities
right-of-use assets obtained in exchange for operating lease obligations
supplemental cash flow information
cash paid for amounts included in the measurement of operating lease liabilities
cash paid for income taxes																																																																										156,000
purchase of treasury stock for net settlement of equity awards		-601,000	-1,353,000	-1,000	-7,000	-358,000	-667,000	-5,000	-9,000	-172,000	-490,000	-3,000	-4,000	-145,000	-428,000	-286,000	0	-88,000
benefit for deferred income taxes
loss on divestitures							0	0	180,000	305,000	548,000	-548,000
gain on sale of building
loss on disposal of pp&e
payments related to acquisitions							0	-468,000	-161,000	-270,000									0	-68,000	-72,500,000	-59,000	-14,425,000				-1,282,000									0	14,000	-2,382,000							0	-193,000	0	-3,180,000	0	-111,000	-4,354,000				-510,000	0	-370,000	-271,000					-184,000	0	0	-575,000		-330,000
proceeds from sale of building																			0
proceeds from sales of marketable securities																			4,900,000	0
proceeds from issuance of convertible senior notes, net of issuance costs paid of 3,234
costs paid related to issuance of convertible senior notes
proceeds from issuance of common stock							1,097,000	0			1,787,000	1,007,000			1,675,000	59,453,000			4,534,000	1,161,000	43,000	233,000	1,718,000	2,130,000	551,000	457,000	160,000	2,071,000	446,000	292,000	30,000	3,169,000	1,482,000	819,000	58,000	714,000	529,000	141,000	1,118,000	2,660,000	733,000	325,000	0	152,000	10,586,000	96,000	520,000	508,000	21,000	170,000	330,000	0			5,000	11,000	37,000	16,000	27,000	83,000			158,000	23,000	0	21,000		113,000	92,000	94,000
payment of deferred acquisition consideration																																							0				-379,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
supplemental disclosures of cash flow information (see notes 8 and 9).
fair value adjustment to contingent consideration obligations				24,000	23,000	23,000		-97,000	23,000	25,000		-27,000	-22,000	-32,000		-553,000	52,000	47,000		19,000	49,000	64,000		44,000	35,000	44,000		-66,000	12,000	30,000
foreign currency effect on net income				-449,000	723,000	-45,000				54,000
net decrease in cash and cash equivalents																		-3,239,000																				-1,510,000				-1,667,000				-2,207,000				-1,146,000				-510,000												-1,802,000				-1,247,000		-4,722,000	-767,000	-2,150,000
payments of long-term debt															0			-7,000,000	-500,000																								0
supplemental disclosures of cash flow information (see notes 6 and 9).
loss on disposal of property and equipment												0																															4,000	0	0	4,000	15,000	0											0								36,000	0			1,000	0
foreign currency transaction (gain) loss																																																				10,000	56,000	220,000		39,000
purchases of property and equipment and other assets								-1,053,000	-2,803,000	-2,130,000		-460,000	-973,000	-536,000		-1,814,000	-1,403,000	-1,059,000		-593,000	-311,000	-863,000		-710,000	-849,000	-802,000		-534,000	-803,000	-427,000		-2,336,000				-566,000
payments of deferred acquisition consideration																								0	-26,000	-33,000		-29,000	-1,107,000	-35,000		-39,000				-206,000
benefit from doubtful accounts									-20,000	-7,000		73,000	81,000	60,000		3,000	74,000	59,000		115,000	71,000	71,000		70,000	98,000	121,000		63,000	73,000	73,000						4,000	-4,000	52,000
foreign currency transaction loss													-491,000	-428,000		336,000	-47,000	33,000		-114,000	-45,000	208,000		125,000	-9,000	-54,000			102,000	-6,000		-14,000												-21,000	18,000	5,000		-19,000	49,000	53,000
benefit from doubtful accounts and allowances
proceeds from revolving line of credit																			0	0
proceeds from issuance of long-term debt																			0	0
payments of revolving line of credit																			-21,000,000
payment of deferred debt issuance costs																			0	0
supplemental disclosures of cash flow information (see notes 7 and 10).
payment of long-term debt
gains on sale of building, acquisitions and divestitures
foreign currency transaction gain																																		-51,000				4,000	-30,000	143,000	-32,000	19,000																-200,000	14,000	-17,000	53,000	-13,000
supplemental disclosures of cash flow information
sales of short-term marketable securities																						3,000,000
proceeds from divestitures
purchase of treasury stock																			-279,000	-234,000	0	-57,000	-237,000	-423,000			-63,000	-673,000			0				-128,000	-181,000			0	-260,000	0	-6,000	0	-204,000	-6,000	-1,000	-39,000	-231,000	-13,000	-90,000	-36,000	-875,000	-508,000	-602,000	-754,000	-937,000	-146,000	-376,000	-1,202,000	-595,000	-399,000	-320,000	-506,000	-168,000	-10,000	-2,000	-29,000	-20,000	-9,000	-8,000
gain on acquisitions and divestitures
supplemental disclosures of cash flow information (see note 12).
gain on divestitures																												0											0
proceeds from divestuture
purchase of intellectual property																																							-11,000				-6,000	-2,000	6,000	-13,000	-23,000
supplemental disclosures of cash flow information (see note 13).
proceeds from divestiture																												0
excess tax benefits from stock-based compensation awards																																											-197,000	0	0	-28,000
proceeds from divestitures, net of expenses																																							0
proceeds from sale of property and equipment
benefit from (recovery of) doubtful accounts
net cashprovidede by (used in) financing activities
inventory																																	335,000	-1,102,000		-480,000	656,000	-392,000	641,000	-384,000	746,000	-395,000	-223,000	-348,000	-1,143,000	-997,000	-225,000	-622,000	-702,000	-619,000	-647,000	-1,183,000	-1,158,000	-737,000	-1,062,000	-376,000	1,231,000	-791,000	-363,000	-525,000	-669,000	-178,000	-245,000	597,000	319,000	-507,000	978,000	791,000	180,000	-476,000
benefit from doubtful accounts and sales allowances																																		48,000
impairment charges																																											68,000	0											0	0	0	83,000									83,000	31,000	48,000	435,000	0	0
provision (recovery) of doubtful accounts																																											23,000	7,000
proceeds from disposal of property and equipment																																								0
accrued contingent earnout
provision of doubtful accounts																																								100,000	4,000	52,000
fair value adjustments to contingent considerations																																											0
receipts related to divestitures																																																			250,000	115,000	131,000	4,000	3,000	1,303,000	102,000	6,000	7,000	2,000
benefit from deferred income taxes																																																						4,000					-2,614,000	94,000	70,000	70,000	14,000	69,000	71,000	70,000
benefit from losses in accounts receivable																																														31,000	22,000			3,000	13,000	51,000	78,000	11,000	-42,000	-34,000	29,000	103,000	1,000	44,000	-18,000	28,000	45,000	9,000	-40,000	61,000	-23,000	23,000	19,000	8,000
net cash provided in financing activities																																														123,000
non cash restructuring charges
payments of italian government loan and grant
supplemental disclosures of cash flow information (see note 14).
purchase of technology and licenses																																																	-112,000	-8,000	-6,000	-42,000	-23,000	-45,000	-17,000	-21,000	-7,000	-19,000	-28,000	-15,000	-10,000	-34,000			-24,000	-1,027,000	-9,000	-2,000	6,000	-109,000
tax benefits from stock-based compensation awards
changes in operating assets and liabilities, net of effect of business acquisitions:
sales and maturities of marketable securities																																																											170,000	172,000	94,000	367,000	2,098,000	159,000	114,000	2,195,000	3,277,000	3,226,000	-165,308,000	173,714,000
(gain) loss on divestitures
noncash restructuring charges																																																								1,000	15,000	709,000
amortization of premium on marketable securities																																																												0
loss on sales of marketable securities																																																																0	0	34,000		-32,000	25,000	17,000
gain on termination of distribution agreement																																																							0
proceeds from italian government loan																																																															4,000
payments of italian government loan																																																											3,000	2,000	2,000	-28,000
accretion of discount (amortization of premium) on marketable securities
investment impairment charges
(gain) loss on sales of marketable securities
abandonment of fixed assets
purchase of property and equipment																																																															-104,000	-276,000	-120,000	-77,000	-40,000	-30,000	-256,000	-298,000	-294,000	-297,000	-298,000	-231,000
purchase of marketable securities
repayment of revolving line of credit																																																																				0	0	-262,000
supplemental disclosures of cash flow information (see note 15).
intangible impairment charges																																																												0				0	33,000	73,000
principal payments on capital lease obligations																																																																							0	0	-6,000	-26,000
expenses associated with equity transactions																																																																							0	0	0	-121,000
amortization (accretion) of premium / discount on marketable securities																																																																13,000	13,000	11,000
impairment loss on marketable securities
purchase of intangible assets
purchases of marketable securities																																																																						-169,800,000
accretion of discount on marketable securities																																																																			-9,000	-19,000	-27,000	-44,000
cash paid for business acquisitions, net of cash acquired
proceeds from sale of impaired assets
other assets																																																																								-62,000	-13,000	14,000
net proceeds from issuance of common stock																																																																									27,000	58,000
proceeds from issuance of common stock pursuant to stock plans
proceeds from initial public offering
proceeds (repayment) under revolving line of credit
proceeds from long-term debt
principal payments on long-term debt
supplemental disclosures of cash flow information (see note 16).
payments related to prior year acquisitions																																																																						-272,000
foreign currency translation adjustment from dissolution of french subsidiary
proceeds from issuance of common stock pursuant to employee stock purchase plan
proceeds from issuance of common stock pursuant to exercise of common stock options
collection of subscription receivable
adjustments to reconcile net income to net cash used by operating activities:
amortization of marketable securities																																																																								-92,000
loss of sale of marketable securities																																																																								0
changes in operating assets and liabilities, net of effects of acquisitions:
inventories																																																																								-185,000	-162,000	-981,000
purchase of available-for-sale securities																																																																								-4,038,000	-2,577,000	-3,259,000
maturities of available-for-sale securities																																																																								1,736,000	2,548,000	3,319,000
cash paid for business acquisition																																																																								-2,504,000
proceeds from sales of common stock under the employee stock purchase plan
proceeds from exercise of common stock options
proceeds under the revolving line of credit
proceeds from short-term debt
principal payments of long-term debt
other
supplemental non-cash financing activities
increase in redemption feature of common stock awards
reclassification of deferred compensation upon adoption of sfas no. 123r
effect of adoption of sfas no. 123r for redemption feature of common stock awards
initial public offering costs included in accounts payable and accrued expenses
cancellation of treasury stock
amortization of deferred compensation
supplemental information
cash paid for interest																																																																										5,000
proceeds from sale of property
purchase of technology license
sale (purchase) of marketable securities
purchase of available for sale securities
maturities of available for sale securities
proceeds/(repayment) under revolving line of credit
issuance of common stock for subscription receivable
common stock issued in connection with acquisitions
reclassification of stock option obligation to additional paid-in capital
effect of adoption of sfas 123r for redemption feature of common stock awards
cancellation of redemption feature as a result of the initial public offering

We provide you with 20 years of cash flow statements for LeMaitre Vascular stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LeMaitre Vascular stock. Explore the full financial landscape of LeMaitre Vascular stock with our expertly curated income statements.

The information provided in this report about LeMaitre Vascular stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.